Biocon inks co-development & commercialisation deal with Lab PiSA for rh-Insulin in USA
Posted on17 Mar 2016
TagsBiocon, Biocon's insulin Glargine, Drug Regulatory body in Maxico, Laboratorios PiSA, Laboratorios PiSA Maxico, PiSA
Comments0
Biocon’s wholly owned subsidiary Biocon SA has entered into an agreement with Laboratorios PiSA S.A. de C.V (PiSA) of Mexico for the... Read More